Implementing AI-Driven Diagnostic Tools to Improve Quality of Life Assessments
DOI:
https://doi.org/10.56294/hl2023237Keywords:
AI-driven diagnostics, quality of life assessments, machine learning, patient-reported outcomes, healthcare innovationAbstract
Abstract: Using artificial intelligence (AI) in the healthcare sector alters doctors' major decision-making process. Evaluating patients' quality of life (QoL) is one area where artificial intelligence seems rather promising. Understanding how various illnesses and therapies influence a person's overall health depends much on quality of life testing. Standard QoL exams, which rely on hand-written assessments and patient comments on their health, have issues like being subjective, biassed, and sluggish when it comes to analyse vast volumes of data. AI-powered testing tools can provide more accurate, quick, scalable methods to evaluate QoL if one is looking for a way around these challenges. This essay examines how artificial intelligence technology could alter the methodology of quality of life surveys. Diagnostics based on artificial intelligence are quite useful. For patient anecdotes, for instance, natural language processing (NLP) may be employed; machine learning techniques can then be used to project QoL values from medical data. AI systems can handle a lot of clinical data including medical records, imaging data, patient-reported results to generate objective, real-time, tailored QoL evaluations consistent and reusable once and again. Furthermore, these instruments can identify early warning indicators of deterioration that would not be evident using more conventional approaches. the usage of several sorts of records sources inclusive of clever tech and cellular fitness apps which increases the accuracy of stories in real time and allows non-stop tracking AI-driven checking out will also be led via This method not handiest courses medical doctors in making better selections however additionally affords people extra manipulate over their fitness, therefore improving their excellent of life over time. The studies additionally addresses moral questions arising from AI-primarily based QoL assessments consisting of data protection, patient permission, and what clinical professionals should do upon assessment of AI outcomes. through discussion of these issues, this take a look at emphasises the need of ensuring that synthetic intelligence generation be applied in a way that complements the interaction among the affected person and company in preference to replaces human know-how.
References
Veta, M.; van Diest, P.J.; Willems, S.M.; Wang, H.; Madabhushi, A.; Cruz-Roa, A.; Gonzalez, F.; Larsen, A.B.L.; Vestergaard, J.S.; Dahl, A.B.; et al. Assessment of algorithms for mitosis detection in breast cancer histopathology images. Med. Image Anal. 2015, 20, 237–248.
Swiderska-Chadaj, Z.; Pinckaers, H.; van Rijthoven, M.; Balkenhol, M.; Melnikova, M.; Geessink, O.; Manson, Q.; Sherman, M.; Polonia, A.; Parry, J.; et al. Learning to detect lymphocytes in immunohistochemistry with deep learning. Med. Image Anal. 2019, 58, 101547.
Bulten, W.; Pinckaers, H.; van Boven, H.; Vink, R.; de Bel, T.; van Ginneken, B.; van der Laak, J.; Hulsbergen-van de Kaa, C.; Litjens, G. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: A diagnostic study. Lancet Oncol. 2020, 21, 233–241.
Raciti, P.; Sue, J.; Ceballos, R.; Godrich, R.; Kunz, J.D.; Kapur, S.; Reuter, V.; Grady, L.; Kanan, C.; Klimstra, D.S. Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies. Mod. Pathol. 2020, 33, 2058–2066.
Ch.V.L.L.Kusuma Kumari. (2015). Performance Appraisal: Dimensions and Determinants. International Journal on Research and Development - A Management Review, 4(3), 27 - 32.
Kompalli Sasi Kumar. (2015). Short Run and Long Run Performance of Indian Initial Public Offerings (IPOs) during 2007-2012. International Journal on Research and Development - A Management Review, 4(3), 33 - 41.
Van Dooijeweert, C.; van Diest, P.J.; Willems, S.M.; Kuijpers, C.C.H.J.; Overbeek, L.I.H.; Deckers, I.A.G. Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: A nationwide study of 4901 patients in the Netherlands. Breast Cancer Res. Treat. 2019, 174, 479–488.
Kuijpers, C.C.H.J.; Sluijter, C.E.; von der Thüsen, J.H.; Grünberg, K.; van Oijen, M.G.H.; van Diest, P.J.; Jiwa, M.; Nagtegaal, I.D.; Overbeek, L.I.H.; Willems, S.M. Interlaboratory variability in the grading of dysplasia in a nationwide cohort of colorectal adenomas. Histopathology 2016, 69, 187–197.
Kuijpers, C.C.H.J.; Sluijter, C.E.; von der Thüsen, J.H.; Grünberg, K.; van Oijen, M.G.H.; van Diest, P.J.; Jiwa, M.; Nagtegaal, I.D.; Overbeek, L.I.H.; Willems, S.M. Interlaboratory variability in the histologic grading of colorectal adenocarcinomas in a nationwide cohort. Am. J. Surg. Pathol. 2016, 40, 1100–1108.
Baeten, I.G.T.; Hoogendam, J.P.; Jonges, G.N.; Jürgenliemk-Schulz, I.M.; Braat, A.J.A.T.; van Diest, P.J.; Gerestein, G.; Zweemer, R.P. Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer. Gynecol. Oncol. 2022.
Epstein, J.I.; Egevad, L.; Humphrey, P.A.; Montironi, R. Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate. Am. J. Surg. Pathol. 2014, 38, e6–e19.
Schnog, J.J.B.; Samson, M.J.; Gans, R.O.B.; Duits, A.J. An urgent call to raise the bar in oncology. Br. J. Cancer. 2021, 125, 1477–1485.
Yue, M.; Zhang, J.; Wang, X.; Yan, K.; Cai, L.; Tian, K.; Niu, S.; Han, X.; Yu, Y.; Huang, J.; et al. Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study. Virchows Arch. 2021, 479, 443–449.
Polesie, S.; McKee, P.H.; Gardner, J.M.; Gillstedt, M.; Siarov, J.; Neittaanmäki, N.; Paoli, J. Attitudes Toward Artificial Intelligence Within Dermatopathology: An International Online Survey. Front. Med. 2020, 7, 1–9.
Forcier, M.B.; Gallois, H.; Mullan, S.; Joly, Y. Integrating artificial intelligence into health care through data access: Can the GDPR act as a beacon for policymakers? J. Law Biosci. 2019, 6, 317–335.
Sculley, D.; Holt, G.; Golovin, D.; Davydov, E.; Phillips, T.; Ebner, D.; Chaudhary, V.; Young, M.; Crespo, J.; Dennison, D. Hidden technical debt in machine learning systems. Adv. Neural Inf. Process. Syst. 2015, 28, 2503–2511.
Published
Issue
Section
License
Copyright (c) 2023 Deepika Sharma, Sudhansu Sekhar Patra, Samuel Jayakumar Sujayaraj , Vasant Devkar (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
